Tristel
Research Tristel (TSTL) on Bullrun: market cap GBX 20.67B, P/E 26.9, dividend yield 3.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTSTL
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyGBX
- Market capGBX 20.67B
- P/E26.9
- Dividend yield3.4%
- Financial periodFY2025
- RevenueGBP 46.46M
- Revenue growth10.8%
- Net incomeGBP 6.64M
- Free cash flowGBP 8.33M
- Gross margin80.6%
Valuation Snapshot
latest market cap is GBX 20.67B; P/E is 26.9; dividend yield is 3.4%.
Peer valuation comparison
Latest P/E is 26.87x versus a Healthcare sector median of 24.46x (9.8% above).
Latest dividend yield is 3.4% versus a Healthcare sector median of 2.11% (61.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 46.46M | GBP 6.64M | GBP 8.33M | 80.6% | n/a | GBP 8.64M | GBP 5.88M | GBP 32.99M |
| FY2024 | GBP 41.93M | GBP 6.49M | GBP 8.70M | 80.1% | 0.14 | GBP 6.14M | GBP 5.86M | GBP 32.41M |
| FY2023 | GBP 36.01M | GBP 4.46M | GBP 6.07M | 77.5% | 0.09 | GBP 7.11M | GBP 5.18M | GBP 30.68M |
| FY2022 | GBP 31.12M | GBP 987.00K | GBP 4.35M | 80.1% | 0.02 | GBP 8.88M | GBP 5.80M | GBP 29.69M |
| FY2021 | n/a | n/a | n/a | n/a | 0.06 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | GBX 20.67B | 26.9 | 3.3% | 0.14 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.14 GBX, yield 3.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 14.2 GBP |
| FY2024 | 13.52 GBP |
| FY2023 | 10.5 GBP |
| FY2022 | 9.55 GBP |
| FY2021 | 6.55 GBP |
About Tristel
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Tristel's market cap?
Tristel's market capitalization is GBX 20.67B.
What is Tristel's P/E ratio?
Tristel's price-to-earnings (P/E) ratio is 26.9.
Does Tristel pay a dividend?
Tristel has a dividend yield of 3.4%.
What does Tristel do?
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.